Balchem (BCPC)
(Delayed Data from NSDQ)
$167.73 USD
+2.97 (1.80%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $167.84 +0.11 (0.07%) 7:58 PM ET
1-Strong Buy of 5 1
F Value C Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BCPC 167.73 +2.97(1.80%)
Will BCPC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BCPC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BCPC
Are Basic Materials Stocks Lagging Balchem (BCPC) This Year?
Zacks.com featured highlights include Kiniksa Pharmaceuticals, HNI, AudioEye, Balchem and The Gorman-Rupp
BCPC: What are Zacks experts saying now?
Zacks Private Portfolio Services
5 Stocks With Recent Price Strength in a Volatile Market
Blachem (BCPC) is on the Move, Here's Why the Trend Could be Sustainable
Blachem (BCPC) Tops Q2 Earnings Estimates
Other News for BCPC
Buy Rating Affirmed for Balchem with Raised Price Target Amidst Strong Profitability and Growth Prospects
Balchem price target raised by $15 at H.C. Wainwright, here's why
BCPC Stock Earnings: Balchem Beats EPS, Misses Revenue for Q2 2024
Blachem: Q2 Earnings Snapshot
Balchem Corporation Reports Second Quarter 2024 Financial Results